Molecular mechanisms of alcoholic fatty liver.

Molecular mechanisms of alcoholic fatty liver.
复制标题

DOI:
10.1111/j.1530-0277.2008.00827.x
复制
发表时间:
2009-02
期刊:
ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH
影响因子:
--
通讯作者:
Song, Byoung-Joon
Song, Byoung-Joon
中科院分区:
其他
文献类型:
--
作者:
Purohit, Vishnudutt;Gao, Bin;Song, Byoung-Joon

文献摘要

参考文献

被引文献

相似文献

酒精性脂肪肝是一种潜在的病理状态,如果继续饮酒,可以进展为脂肪性肝炎,纤维化和肝硬化。酒精暴露可通过增加NADH/NAD+比值、增加固醇调节元件结合蛋白-1(SREBP-1)活性、降低过氧化物酶体增殖物激活受体-α(PPAR-α)活性和增加肝脏补体C3水平诱导脂肪肝。酒精可通过降低AMP活化蛋白激酶和sirtuin-1的活性来增加SREBP-1的活性。酒精暴露后产生的肿瘤坏死因子-α(TNF-α)可能通过上调SREBP-1活性导致脂肪肝,而甜菜碱和吡格列酮可能通过下调SREBP-1活性减轻脂肪肝。PPAR-α激动剂具有减轻酒精性脂肪肝的潜力。脂联素和白细胞介素-6可能通过上调PPAR-α和胰岛素信号通路,下调SREBP-1活性,抑制TNF-α的产生而减轻酒精性脂肪肝。最近的研究表明,肝星状细胞来源的内源性大麻素旁分泌激活肝大麻素受体1也有助于酒精性脂肪肝的发展。此外,参与脂肪酸的线粒体和/或过氧化物酶体β-氧化的酶的氧化修饰和失活可能有助于肝脏中的脂肪蓄积。
Alcoholic fatty liver is a potentially pathologic condition which can progress to steatohepatitis, fibrosis, and cirrhosis if alcohol consumption is continued. Alcohol exposure may induce fatty liver by increasing NADH/NAD+ ratio, increasing sterol regulatory element-binding protein-1 (SREBP-1) activity, decreasing peroxisome proliferator-activated receptor-α (PPAR-α) activity, and increasing complement C3 hepatic levels. Alcohol may increase SREBP-1 activity by decreasing the activities of AMP-activated protein kinase and sirtuin-1. Tumor necrosis factor-α (TNF-α) produced in response to alcohol exposure may cause fatty liver by up-regulating SREBP-1 activity, whereas betaine and pioglitazone may attenuate fatty liver by down-regulating SREBP-1 activity. PPAR-α agonists have potentials to attenuate alcoholic fatty liver. Adiponectin and interleukin-6 may attenuate alcoholic fatty liver by up-regulating PPAR-α and insulin signaling pathways while down-regulating SREBP-1 activity, and suppressing TNF-α production. Recent studies show that paracrine activation of hepatic cannabinoid receptor 1 by hepatic stellate cell-derived endocannabinoids also contributes to the development of alcoholic fatty liver. Furthermore, oxidative modifications and inactivation of the enzymes involved in the mitochondrial and/or peroxisomal β-oxidation of fatty acids could contribute to fat accumulation in the liver.
DOI: 10.1080/07853890600664608
发表时间: 2006-01-01
期刊: ANNALS OF MEDICINE
影响因子: 4.4
作者:
Bykov, Igor;Junnikkala, Sami;Meri, Seppo
通讯作者: Meri, Seppo
DOI: 10.2337/diacare.28.12.2933
发表时间: 2005-12-01
期刊: DIABETES CARE
影响因子: 16.2
作者:
Beulens, JWJ;Stolk, RP;Bots, ML
通讯作者: Bots, ML
DOI: 10.1093/alcalc/agg066
发表时间: 2003-05-01
影响因子: 2.8
作者:
Aleynik, SI;Lieber, CS
通讯作者: Lieber, CS
DOI: 10.1097/01.alc.0000169265.36440.ee
发表时间: 2005-06-01
影响因子: 3.2
作者:
Blasco, C;Caballería, J;Rodés, J
通讯作者: Rodés, J
DOI: 10.1016/j.jhep.2006.11.020
发表时间: 2007-05-01
影响因子: 25.7
作者:
Bykov, Igor;Jauhiainen, Matti;Meri, Seppo
通讯作者: Meri, Seppo